New Strategies and Drugs Against Intracellular Pathogens
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 3102
Special Issue Editors
Interests: parasite; protein; antimalarial drugs
Special Issues, Collections and Topics in MDPI journals
Interests: toxoplasmosis; natural products; drugs; immunity
Interests: malaria; hematology; antigen; antibody; vaccine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The infectious diseases, such as Mycobacterium tuberculosis, Plasmodium falciparum and human immunodeficiency virus, caused by intracellular pathogens pose the most profound impact on public health. Despite being caused by different organisms, the intracellular infectious diseases present a series of challenges in emergency, infection persistence, and drug resistance, highlighting the urgent need for new and deeper insights into surveillance, pathobiology of these diverse invaders and disease interventions. To face these challenges, new methods or drugs that facilitate the efficient treatment and prevention of the pathogens are required continually.
The Special Issue “New Strategies and Drugs Against Intracellular Pathogens” aims to present the most recent achievements in drug screen, drug sensitivity and resistance mechanisms, especially new compounds such as Natural product molecules or new inhibitors, which predict important advances in treatment of diseases caused by intracellular pathogens. Manuscripts, together with review papers, will summarize the “state of the art” of the strategies and drugs of intracellular pathogens.
Dr. Feng Lu
Dr. Siyang Huang
Dr. Jin Hee Han
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- intracellular pathogen
- method
- drug
- drug screen
- drug sensitivity
- resistance
- natural product
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
